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A B S T R A C T
The chemical and functional interactions between Reactive Oxygen (ROS), Nitrogen (RNS) and Sulfur (RSS)
species allow organisms to detect and respond to metabolic and environmental stressors, such as exercise and
altitude exposure. Whether redox markers and constituents of this ‘Reactive Species Interactome’ (RSI) differ in
concentration between arterial and venous blood is unknown. We hypothesised that such measurements may
provide useful insight into metabolic/redox regulation at the whole-body level and would be consistent between
individuals exposed to identical challenges. An exploratory study was performed during the Xtreme Alps ex-
pedition in 2010 in which four healthy individuals (2 male, 2 female) underwent paired arterial and central
venous blood sampling before, during and after performance of a constant-work-rate cardiopulmonary exercise
test, at sea level and again at 4559m. Unexpectedly, plasma total free thiol and free cysteine concentrations
remained substantially elevated at altitude throughout exercise with minimal arteriovenous gradients. Free
sulfide concentrations changed only modestly upon combined altitude/exercise stress, whereas bound sulfide
levels were lower at altitude than sea-level. No consistent signal indicative of the expected increased oxidative
stress and nitrate→nitrite→NO reduction was observed with 4-hydroxynonenal, isoprostanes, nitrate, nitrite,
nitroso species and cylic guanosine monophosphate. However, the observed arteriovenous concentration dif-
ferences revealed a dynamic pattern of response that was unique to each participant. This novel redox meta-
bolomic approach of obtaining quantifiable ‘metabolic signatures’ to a defined physiological challenge could
potentially offer new avenues for personalised medicine.
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Redox reactions constitute one of the most fundamental integrative
regulatory systems that support human physiology, and our understanding
of these systems has evolved at a remarkable rate in recent years. Redox
reactions are intimately linked to both, oxidative stress and cellular bioe-
nergetics. Over the past decade, the ‘oxidative stress’ concept (much of
which initially revolved around cellular damage pathways associated with
the formation of reactive oxygen species; ROS) evolved to become under-
stood as a vital component of a wider ‘Redox Code’ that underpins most
cellular signalling pathways and regulatory functions [20,38,39]. Beyond
ROS, however, many other small reactive molecules are also involved in
this regulation including reactive nitrogen species (RNS) and reactive sulfur
species (RSS) [13,14]. As well as controlling whole body metabolism, the
chemical and functional interactions between these species (which we re-
cently defined to constitute the ‘Reactive Species Interactome’; RSI [5])
allows organisms to sense and adapt to the many environmental stressors
they experience throughout everyday life. We believe characterisation of
these processes to be absolutely essential to arrive at a truly integrative
understanding of human physiology in health and disease, although it is not
clear at the moment what exactly we should measure to gauge the func-
tional status of this RSI and its key regulatory nodes.
ROS, RNS and RSS are now emerging as equally important signalling
molecules in their own right; targeting gene transcription, ion transport,
metabolic activity and mitochondrial function [5,14]. The ‘gasotransmitters’
nitric oxide (NO) and hydrogen sulfide (H2S) are the most prominent re-
presentatives of the RNS and RSS group of regulatory species, with perox-
ynitrite (ONOO-; [37]) and nitrosopersulfide (SSNO-; [6]) representing
products of their chemical interaction with ROS [5]. The same protein
targets that had been recognised as important players in the ROS/oxidative
stress field earlier, cysteine redox switches, also seem to interact with RNS
and RSS, leading to additional–sometimes similar but often distinct -
downstream effects. The interaction of the cysteine thiol with RNS leads to
formation of S-nitrosothiols (RSNO). S-nitros(yl)ation has long been re-
cognised as prototypic post-translational redox modification [40], although
the notion that RSNOs serve as important signalling entities has recently
been challenged [36,46]. By comparison, reaction of the same cysteine
residues with RSS promotes formation of persulfide and polysulfide species.
This sulfuration reaction, which is also known as S-sulfhydration in the
biological literature dealing with H2S research [46], appears to be abundant
and its products seem to have similarly widespread regulatory signalling
functions [11,17]. While the notion that sulfane sulfur is important for cell
function is not new [43], this field is conceptually still in its infancy.
The tripeptide glutathione is known to be crucial for intracellular anti-
oxidative defense by virtue of its reactive free cysteine thiol while serving as
a cofactor for peroxidases and phase-II detoxification enzymes [28]. The
cysteine required for its synthesis is transported, largely in the form of its
disulfide, in the blood and taken up by cells via specific membrane trans-
porters (e.g. the xCt antiporter system, in exchange for intracellular gluta-
mate; [25]). In addition, homocysteine and cysteinylglycine are transported,
in their free forms and as mixed disulfides, in blood. Circulating reduced,
oxidized and protein-bound forms of these aminothiols have been defined
to comprise the ‘plasma redox status’ [44], but relatively little is known
about its regulation or the significance of individual constituents for ex-
tracellular redox status. More recently, the relative proportion of reduced
and oxidized cysteine and glutathione in human plasma was found to be
associated with the risk of death from coronary artery disease [35]. Un-
expectedly, even the concentration of serum total free thiols was found to
predict outcome in clinical conditions ranging from renal to cardiac disease
[10,22]; this may be due to the enhanced formation of cysteine and glu-
tathione adducts with albumin under conditions of oxidative stress [5].
Even circulating sulfate, the final oxidation product of H2S and also a
dietary constituent, may be of prognostic value in disease settings associated
with oxidative stress [21]. In parallel with the renewed interest in the
biological effects of these aminothiols and other sulfur-based mediators and
biomarkers in biology, our group recently developed a novel mass
spectrometry-based method that allows rapid and specific quantification of
the plasma thiol metabolome with simultaneous measurement of ami-
nothiols and sulfide [42].
Both, exercise and high altitude (hypobaric hypoxia) exposure represent
two common but challenging physiological and metabolic stressors that are
well recognised to result in significant perturbations in redox balance
[19,30,45]. Historically, most studies have focused on how hypobaric hy-
poxia affects the production of ROS and RNS [22], while the role of RSS in
altitude acclimatisation remains largely unknown. Moreover, as with most
other clinical and physiological situations to date, previous studies have
tended to limit examination of how the concentrations of redox system
read-outs change to the peripheral venous circulation.
Recent work has shown that arterial and venous profiles of many me-
tabolic markers, including those known to directly influence redox systems
such as glutamate, differ in peripheral muscle compartments at sea level
[18], and our own group has shown that tissue oxygen extraction remains
relatively preserved at altitude despite oxygen uptake being limited [26].
The stable breakdown products that are generated as a result of formation
and interaction of ROS, RNS and RSS with each other and their biological
targets are usually not quantified in the arterial side of the circulation at
altitude. To the best of our knowledge, the potential significance of any
arteriovenous concentration differences in redox thiol status, in particular
that of sulfide-related species, has not been explored.
We hypothesised that significant differences between arterial and ve-
nous plasma concentrations would be seen for many redox markers during
exercise, and that these differences would be further exacerbated at altitude.
We further expected that, while magnitudes of responses might differ be-
tween individuals, the overall direction of the responses would be consistent
in participants exposed to identical challenges.
2. Methods
Full details of the conduct of the Xtreme Alps 2010 expedition have
been published elsewhere [7,27]. The work presented here was part of a
small pilot sub-study performed alongside the main Xtreme Alps re-
search project. All participants gave written informed consent, and
ethical approval was received from the research ethics committees at
both University College London, UK and the University of Turin, Italy.
2.1. Overall study design
Four participants (2 male, 2 female) of the laboratory team, not
enrolled as study subjects in the main Xtreme Alps 2010 study, un-
derwent paired arterial and venous blood sampling before, during and
after performance of a constant work rate cardiopulmonary exercise
test (CPET) at near sea-level in London, UK (75m), and again at the
Margherita Hut high altitude research laboratory (4559m).
2.2. Ascent profile
Following air travel to Milan, Italy, and immediately after transfer
by coach to Alagna (1200m), all participants ascended by cable car to
Punta Indren (3200m) and then walked to the Gnifetti Hut (3647m).
Subjects continued to climb on foot to the Margherita Hut (4559m)
after spending 2 nights at 3647m. Measurements for this study protocol
were taken on days 5 and 6 at 4559m (i.e. days 7 and 8 at altitude). By
this time every subject was well acclimatized, and no evidence of acute
altitude illness or any other contra-indication to exercise testing was
present. Mean barometric pressure during testing periods at sea level
and altitude were 101.7 kPa and 58.1 kPa respectively.
2.3. Exercise testing
Exercise tests were performed on an electronically braked cycle
ergometer exercise bike (Lode Corival; Lode, Groningen, Netherlands)
and breath-by-breath analysis of inspired/expired oxygen and carbon
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dioxide was achieved using a cardiopulmonary exercise testing system
(Metamax 3b; Cortex, Leipzig, Germany). This system has been pre-
viously validated at high altitude and used successfully at altitudes up
to almost 8000m by our group [24]. All subjects properly fasted before
commencing the test and maintained a pedalling cadence of 60 rpm
throughout the exercise protocol.
After sitting stationary on the exercise bike for 3min (‘rest’) and a
further 3min of unloaded cycling, subjects cycled at three steady-state
work rates (20, 40 and 60 W) for 10min each, before stopping the
exercise (see Fig. 1). These work rates were selected to target the ex-
ercise intensity of participants cycling to be below their anaerobic
threshold at sea-level and at altitude, based on our group's previous
exercise studies at altitude [12,24,27]. At altitude all subjects had an
extra 3min of rest. Physiological observations were recorded
throughout each test using a non-invasive blood pressure cuff on the
upper arm and a pulse oximeter placed on the right index finger.
2.4. Catheter placement and blood sampling
Immediately before each exercise test, an experienced anaesthetist
and/or intensivist inserted a central venous catheter into each subject's
right internal jugular vein (using a standard Seldinger technique under
ultrasound guidance) and placed an arterial catheter into the non-
dominant radial artery.
Paired central venous and arterial blood samples were collected
from these catheters simultaneously by 2 investigators in the last
minute of the rest period (time point 1), 8 min into each constant work
rate period (time points 2, 3 and 4, respectively) and 3min after
stopping exercising (time point 5), as illustrated in Fig. 1. pH, arterial
partial pressure of oxygen (PaO2) and arterial partial pressure of carbon
dioxide (PaCO2) readings from each sample were recorded immediately
using a Siemens blood gas analyser (validated and used at similar al-
titudes in previous studies by our group) [15,24].
2.5. Blood processing and analysis
Separate aliquots were collected with EDTA as anticoagulant right after
those harvested for blood gas analyses, immediately subjected to cen-
trifugation to obtain plasma, aliquoted at altitude and kept frozen at
−40 °C (both at sea level and at high altitude) before transfer on dry ice
into a −80 °C freezer for long-term storage. Final biochemical sample
analysis was carried out in Southampton, UK. Plasma biomarker con-
centrations were quantified in batches of no more than 20 samples in a
staggered fashion; samples for NO metabolite and thiol metabolome ana-
lysis were pretreated with N-ethylmaleimide (NEM) whereas those for other
biomarkers were used immediately after thawing without further derivati-
zation. For the former, frozen plasma aliquots were thawed in the presence
of an excess of NEM in PBS to achieve a final concentration of 10mM; this
was accomplished by adding a 100mM NEM stock in 100mM ammonium
phosphate (pH 7.40) at a 1:10 (v:v) ratio to a sample aliquot immediately
after thawing, followed by vortexing. Daily calibrations with authentic
standards were performed for all biochemical assays (and all glassware,
collection tubes and pipettes were rinsed with ultrapure water to reduce
background contaminant levels of nitrite and nitrate). Analyses were per-
formed at least in duplicate and values averaged, except for nitrite, nitrate,
sulfate, thiosulfate and RXNO where only a single determination was per-
formed due to sample volume limitations.
Commercially available ELISA/EIA assays were used to quantify the
concentrations of 4-hydroxynonenal (4-HNE; STA-838; Cell Biolabs San
Diego, USA), 8-isoprostane (8-IsoPG; 516630; Cayman Chemicals, Ann
Arbor, Michigan, USA) and cyclic GMP (cGMP; KGE003; R & D Systems,
Minneapolis, USA), and all kits performed in accordance with the manu-
facturer's instructions and protocols. Nitrate (NO3-) and nitrite (NO2-) con-
centrations were quantified using a dedicated high-performance liquid
chromatography analyser (ENO20, Eicom) following sample deproteinisa-
tion by precipitation with methanol and centrifugation at 16,000×g for
20min. Concentrations of total nitrosation products (RXNO) were measured
Fig. 1. Blood sampling points (A) with
approximate positions of central ve-
nous and radial artery catheters; si-
multaneous drawing of arterial (red
circle) and venous blood (blue circle)
during exercise at high altitude (B); and
exercise protocol with time points at
which blood was collected for im-
mediate pH/blood gas and later bio-
marker analysis (C). See Methods for
details. (For interpretation of the re-
ferences to color in this figure legend,
the reader is referred to the web ver-
sion of this article).
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by gas-phase chemiluminescence of bound NO following reductive deni-
trosation. Nitrite was removed from NEM-treated EDTA plasma by reaction
with acidic sulfanilamide prior to analysis, followed by injection of treated
aliquots into an acidic triiodide-containing reduction chamber, and the
amount of NO liberated from low-molecular weight and protein nitroso-
species was quantified by a gas-phase chemiluminesence analyser (CLD
77 am sp, EcoPhysics), as previously described [9,23]. Total “antioxidant
power” was measured by the Ferric Reducing Activity of Plasma (FRAP)
assay [2]. The concentrations of total free thiols (TFTs) in plasma were
determined spectrophotometrically using Ellman's reagent [22]. Plasma
concentrations of sulfate (SO42-) and thiosulfate (S2O32-) were quantified
after separation on a Dionex IonPac AS11-HC-4 µm column and detected as
the monoprotonated species using ion chromatography mass spectrometry
(IC-MS; Dionex ICS-5000+ system, Thermo Scientific). Ultrahigh-perfor-
mance liquid chromatography in combination with electrospray-ionization
tandem mass spectrometry (LC-ESI-MS/MS) was used to separate and
quantify all of the remaining analytes including sulfide and biological
aminothiols such as cysteine, N-acetylcysteine, homocysteine, glutathione,
cysteinylglycine, and glutamylcysteine in the form of NEM-adducts as de-
scribed in detail by our group elsewhere [42]. In addition to the free thiols,
their total concentrations (free + protein-bound forms and disulfides) were
determined after sample pre-processing with dithiothreitol (DTT). For this
purpose, already NEM-reacted sample aliquots were subjected to reduction
by addition of an excess of DTT at room temperature, as described in detail
elsewhere [42]. This procedure works even with NEM-pretreated samples
(as DTT also reacts with this alkylans), provided the excess NEM is first
neutralized by an adequate concentration of DTT (beyond what is required
for reduction of bound thiols after NEM neutralization), followed by sub-
sequent incubation for 30min at room temperature to achieve complete
reduction and addition of another excess of NEM for derivatization of the
liberated thiols [42]; appropriate dilutions in 10 mM ammonium phosphate
buffer were made before subsequent analysis by LC-MS/MS. Because
plasma samples were not treated with NEM immediately after centrifuga-
tion, the oxidized form are artificially elevated, preventing us from calcu-
lating accurate redox ratios; therefore, concentrations of oxidized thiols are
not reported.
2.6. Statistical analysis
Physiological observational and blood gas data were all treated as non-
parametric, and results are therefore presented as median (range) for these
values. For blood gas data, significance was assumed if p < 0.05 using the
Wilcoxon Signed-Rank Test. Results of plasma biomarker analyses are
presented as mean± SD in tables whereas, for the sake of clarity of pre-
sentation, only the means are displayed in the figures. All calculations and
figures were produced using GraphPad Prism 7.0.
3. Results
3.1. Exercise test performance and sample collection
All 4 subjects reached 4559m and remained at this altitude for the
full duration of the expedition. One subject was initially unwell at
4559m, developing symptoms of acute mountain sickness shortly after
arrival at 4559m, but these had fully resolved before commencing the
exercise protocol. All venous and arterial catheters were successfully
inserted on the first attempt without any complications. Similarly, all
exercise tests at sea level and at altitude were completed successfully
without any problems; moreover, all samples were collected according
Table 1
Study participants’ (P1, P3 male; P2, P4 female) blood pressure
(BP; mmHg), heart rate (HR; beat per minute, bpm) and periph-
eral oxygen saturation (SpO2; %) recorded at rest (T1), during
exercise (T2-T4) and in early recovery (T5), at sea level and at
altitude.
Table 2
Concentrations of study participants’ (P1, P3 male; P2, P4 female)
circulating total free thiols (TFT) and total antioxidants (Ferric
Reducing Ability of Plasma assay, FRAP) recorded at rest (T1),
during exercise (T2-T4) and in early recovery (T5), at sea level
and at altitude.
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to plan and either analysed immediately (pH, blood gases) or processed
and frozen (for later analysis of biomarkers) as above.
Normal physiological responses to exercise were observed
throughout each test. Participants’ blood pressure and heart rate both
increased at higher exercise work rates, whilst peripheral oxygen sa-
turations decreased (see Table 1). One blood pressure reading could not
be recorded at 60W due to erratic readings during that level of exertion
in this subject.
3.2. Blood gas analyses
Arterial pH decreased from 7.44 (7.43–7.46) at rest to 7.43
(7.42–7.44) at 60 W at sea level. Similarly, the 60 W work rate at
4559m was associated with a decrease in arterial pH from 7.49
(7.45–7.52) at rest to 7.45 (7.43–7.48). Resting PaO2 significantly de-
creased from 12.7 (11.4–13.2) kPa at sea level to 6.8 (6.3–7.0) kPa with
exposure to the hypobaric hypoxia at 4559m altitude (p < 0.001).
Resting PaCO2 also significantly decreased from 5.6 (5.3–6.4) kPa at sea
level, to 3.3 (3.1–3.8) kPa at 4559m (p < 0.001).
3.3. Plasma biomarkers
Changes in total free thiols (TFT) and cysteine levels are shown in
Table 2 (and graphically in Supplementary Figure 6) and Fig. 2, re-
spectively, with levels of both markedly increasing under hypoxic
conditions at altitude in all subjects. These changes persisted and re-
mained relatively unchanged throughout all levels of exercise with
minimal arteriovenous differences during this observation period. By
contrast, circulating sulfate and thiosulfate concentrations (Fig. 4) were
lower upon exposure to hypobaric hypoxia. Despite this, only relatively
minor changes to circulating sulfide levels were seen throughout ex-
ercise, both at sea level and at altitude (Fig. 3). As previously reported
for healthy volunteers residing at sea level [42], concentrations of
bound cysteine and sulfide exceeded free levels by orders of magnitude
Fig. 2. Steady-state arterial (red) and venous (blue) concentrations of free and total (T; shaded area) cysteine in study participants’ (P1, P3 male; P2, P4 female)
plasma at rest T1, T2–T4, and T5, during exercise [2–4] and in early recovery [5], at sea level (SL, circles and squares) and at high altitude (ALT–light triangles). (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
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(Figs. 2, 3). No consistent differences in free/total N-acetylcysteine,
homocysteine, glutathione, cysteinylglycine and glutamylcysteine were
observed between sea level and altitude (see Supplementary Figures
1–5).
Results of nitrate (NO3-), nitrite (NO2-), total nitroso species (RXNO)
and cyclic guanosine monophosphate (cGMP) measurements are shown
in Table 3. Only rather moderate differences were observed in total
plasma antioxidant power (FRAP; Table 2) and oxidative stress markers
such as 4-hydroxynonenal (HNE) and 8-isoprostanes, which are shown
in Fig. 5 and Table 4, respectively. No consistent signal indicative of
elevated oxidative stress was apparent at high altitude, nor was there an
indication for the expected nitrate and/or nitrite reduction in hypoxia
(or an increased NO bioavailability). Measurements of each of these
markers varied greatly between different participants, in both arterial
and venous compartments, and at each stage of exercise. However,
when all of the biomarkers measured were combined and plotted as
arteriovenous concentration differences for each sampling condition
(see Fig. 6), distinct redox profiles emerged that suggested substantial
differences in dynamic responses of individual contributors to the RSI.
When expressed this way, each participant demonstrated a unique re-
sponse pattern to the metabolic stress of exercise under normoxic and
hypoxic conditions.
4. Discussion
The results from our present study demonstrate that exposure to
hypobaric hypoxia is accompanied by markedly higher concentrations
of circulating cysteine and protein free thiols yet lower concentrations
of sulfate and thiosulfate, with only moderate changes in other ami-
nothiols and sulfide. In addition, the concentration of various other
constituents of the RSI differed between the arterial and venous side of
the circulation, indicative of either net consumption or production of
these substances or their precursors upon passage through body organs.
Importantly, although the nature of the metabolic (exercise) and
Fig. 3. Steady-state arterial (red) and venous (blue) concentrations of free and total (T; shaded area) sulfide in study participants’ (P1, P3 male; P2, P4 female) plasma
during rest [1], exercise [2–4] and early recovery [5] at sea level (SL, circles and squares) and at high altitude (ALT–light triangles). (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of this article).
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Fig. 4. Arterial (red) and venous (blue) steady-state concentrations of sulfate and thiosulfate in study participants (P1, P3 male, P2, P4 female) at rest (T1), during
exercise (T2–4) and in early recovery (T5) at sea level (SL; circles and squares) and at high altitude (ALT–light triangles). Missing data points were due to insufficient
sample volumes available. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
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environmental (hypobaric hypoxia at altitude) stresses experienced by
each participant were identical, the magnitude and directionality of the
responses to these combined stressors markedly differed between in-
dividuals. In particular, the bound thiol pool (including sulfide) showed
a surprising dynamic that may be used to characterize the redox me-
tabolomic phenotype of individuals and perhaps serve as a useful tool in
personalizing medicine in the future.
We believe this study to be the first in reporting field measurements
of RSS and arteriovenous gradients of redox biomarkers at high alti-
tude. The challenges of performing invasive field studies at altitude are
substantial and frequently limit sample sizes in such studies; never-
theless, results of other (identically powered) altitude studies have
demonstrated interesting findings with the potential for significant
impact [15,26]. Our current study now demonstrates that arteriovenous
gradients of plasma biomarkers can safely be determined at altitude
without complications. Central venous catheters were chosen rather
than full pulmonary artery catheters because of the increased number of
adverse events associated with pulmonary artery catheter insertion;
however, using a relatively low insertion approach in the right internal
jugular vein under ultrasound guidance, all catheters should have sat in
the superior vena cava giving access to blood that reflects true central
venous values [26].
We have demonstrated robust elevations in TFT concentrations at
altitude throughout all stages of exercise and although the significance
of this response is uncertain, such a marked and consistent response
across all subjects suggests a tightly regulated response to hypoxia. This
result was unexpected and contrary to our hypothesis that circulating
free thiol levels would be lower under conditions of chronically ele-
vated oxidative stress, which typically prevails at high altitude [19,23].
Other studies have suggested increased TFT concentrations are asso-
ciated with improved cardiovascular outcomes and patient survival
[10,22], possibly by acting as antioxidant ‘buffer’ to ROS and reducing
harmful oxidative stress [4]. Plant studies have also suggested thiol
concentrations increase at moderate altitudes in lichens to confer pro-
tection against increased free radical formation [16]. Similarly, in-
tracellular protein thiols have been demonstrated to sense and regulate
cellular responses to hypoxia, including regulatory cysteines within the
Na+,K+-ATPase that are thought to confer this critical enzyme's ability
to sense oxygen levels [3]. Thiol availability may also alter production
of other reactive species, particularly NO [32], allowing further sig-
nalling crosstalk in response to hypoxic stress. What accounts for the
higher TFT concentrations at altitude warrants further investigation,
but a likely possibility is enhanced cleavage of circulating mixed dis-
ulfides by extracellular or outer membrane reductases (such as protein
disulfide isomerase and other members of the thioredoxin family;
[29,33]). This may, in part, be captured by the unspecific “antioxidant
power” assay, FRAP (see Table 2). Consistent with literature data,
documenting a higher activity for men compared to women [1], FRAP
was robustly elevated at altitude only in the two male participants.
Since S-cysteinylated albumin is an established marker of oxidative
stress [34] and residence at altitude is typically associated with higher
oxidative stress, such a mechanism would also account for the elevated
free cysteine levels observed at altitude. Remarkably, circulating free
sulfide levels did not change with altitude although the concentrations
of its oxidation products, thiosulfate and sulfate were lower than at sea
level. These observations are consistent with alterations in flux through
the transsulfuration pathway, which is known to be redox-sensitive
[31].
Changes in other biomarker concentrations in response to these
stressors were much more variable, for example 4-HNE (the protein
adduct of a reactive lipid oxidation product) concentrations differed by
several orders of magnitude between individuals, both at baseline and
during exercise. Reasons for these differences are likely multifactorial
while still consistent with previous studies.
Levels of nitrate in this study were similar to those reported pre-
viously by our group in other cohorts sojourning at similar altitudes in
Table 3
Plasma concentrations of study participants’ (P1, P3 male; P2, P4 fe-
male) nitric oxide related biomarkers including nitrate, nitrite, nitroso
species (RXNO) and cyclic guanosine monophosphate (cGMP) recorded
during rest, exercise and early recovery at sea level and at high altitude.
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Fig. 5. Arterial (red) and venous (blue) steady-
state plasma concentrations of 4-hydro-
xynonenal (HNE) in study participants (P1, P3
male; P2, P4 female) at rest (T1), during ex-
ercise (T2-T4) and in early recovery (T5), at
sea level (SL; circles and squares) and at high
altitude (ALT; light triangles). (For interpreta-
tion of the references to color in this figure
legend, the reader is referred to the web ver-
sion of this article).
Table 4
Study participants’ (P1, P3 male; P2, P4 female) circulating 8-isoprostane (8-isoPG) concentrations in arterial and
venous plasma at rest (T1), during exercise (T2-T4) and in early recovery (T5), at sea level and at altitude.
Arterial 5992.4 ± 43.4 13035.7 ± 3453.1 5264.6 ± 940.1 6965.3 ± 472.2
Venous 4307.7 ± 907.4 12781.7 ± 548.0 6173.1 ± 746.6  6539.0 ± 430.8
Arterial 6148.6 ± 88.8 10698.3 ± 933.3 5904.3 ± 741.3 5511.2 ± 112.4
Venous 4132.0 ± 482.2 11858.6 ± 926.7 6633.4 ± 195.7 5514.9 ± 262.5
Arterial 3955.6 ± 944.4 11149.3 ± 2295.5 5465.0 ± 323.0 5823.4 ± 405.0
Venous 4882.0 ± 578.5 13912.2 ± 156.6 6701.0 ± 312.2 5287.4 ± 353.0
Arterial 5083.5 ± 26.3 11282.0 ± 338.5 6916.7 ± 1158.0 5484.0 ± 356.8
Venous 4187.5 ± 181.6 11876.2 ± 732.5 6771.8 ± 545.8 6921.8 ± 312.2
Arterial 4632.6 ± 447.9 12870.5 ± 138.6 6208.5 ± 311.0 6428.5 ± 741.3
Venous 6415.8 ± 812.1 11015.8 ± 1191.9 6234.4 ± 232.1 5813.7 ± 685.1
Arterial 7146.8 ± 293.8 7309.5 ± 116.5 5677.1 ± 969.7 7089.2 ± 556.8
Venous 5172.2 ± 315.1 7741.8 ± 253.9 5458.6 ± 110.9 8756.5 ± 1551.3
Arterial 6208.3 ± 683.5 6709.6 ± 397.6 6205.8 ± 222.1 7332.2 ± 585.3
Venous 6662.6 ± 355.0 8709.8 ± 982.4 5537.0 ± 630.4 6405.4 ± 418.1
Arterial 7976.9 ± 2018.8 7544.4 ± 118.1 6701.0 ± 204.9 7716.9 ± 568.8
Venous 9404.4 ± 776.2 8015.1 ± 897.9 6637.1 ± 1165.0 6864.7 ± 636.6
Arterial 6104.2 ± 1362.7 7375.4 ± 853.5 7389.8 ± 457.8  8315.8 ± 370.9
Venous 8295.0 ± 912.5 8614.7 ± 1410.5 7358.6 ± 625.0 7614.5 ± 186.1
Arterial 7443.7 ± 1362.9 7606.4 ± 656.1 7515.7 ± 527.8 8416.9 ± 881.3
Venous 9070.4 ± 644.5 9650.4 ± 1156.3 6986.1 ± 788.6 7622.0 ± 434.5
[8-isoPGF 2α], pg mL













A.F. Cumpstey et al. Redox Biology 21 (2019) 101113
9
Fig. 6. Pattern of responses to the physiological stress of skeletal muscle activity (bicycle exercise) at sea level and high altitude. Exemplary differences in absolute
steady-state concentrations of various redox markers in arterial and venous plasma during rest (T1), exercise (T2-T4) and in early recovery (T5) in study participants
(P1, P3 male; P2, P4 female) are plotted for test results obtained at normoxia (sea level) and during chronic hypoxia (altitude). Values above the horizontal bar
denote higher venous than arterial concentrations and vice versa (units omitted for sake of clarity).
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Nepal [22], while levels of nitrite were much lower in this group albeit
still similar to levels reported by others [8]. This could be due to dif-
ferent dietary intakes by these different groups–everyone on the Xtreme
Alps expedition (including those participating in this study) consumed a
low nitrate diet as an important dietary element of the expedition's
main study [7,27]. Venous cGMP concentrations were also similar to
previous measurements in Nepal [23]. Interestingly though, arterial
concentrations were generally higher in this cohort, with the sub-
sequent arteriovenous gradient perhaps suggesting that the increased
NO availability seen at altitude is more predominant in the pre-
ferentially well-oxygenated arterial side of the circulation.
Measurement of plasma biomarker arteriovenous gradients has
previously been proposed as a more sensitive way of detecting meta-
bolic changes in individuals, and–by choosing from which artery and
vein blood is sampled - could also allow a relatively simple way of
monitoring organ specific changes in different disease states [18]. The
A/V concentration differences observed using the approach applied in
the current study are a reflection of whole-body metabolism, which–-
taking flow rates into account–should also allow to calculate uptake/
consumption and/or production rates. Although ‘omic’ study ap-
proaches have recently started being applied to the altitude environ-
ment [41], the additional information that arteriovenous gradients may
provide in the context of metabolomic approaches at altitude have
never been explored before. Furthermore, the lack of any apparent in-
crease in tissue oxygen extraction at altitude suggests that adaptations
occur on a cellular level to improve tissue oxygen handling in this en-
vironment [26]. These may include subtle redox-related metabolic
changes that might not be detectable otherwise.
Our study has strengths and limitations. Its strength relates to the
relatively large number of analytes assessed in both arterial and venous
plasma samples, in a longitudinal fashion during graded metabolic
stress, both at sea level and at high altitude. However, our study is
essentially preliminary as samples were only obtained from four in-
dividuals. A clear limitation is the long duration between collection and
analytical analysis of the samples (approximately 8 years) during which
time the concentration of some analytes may have changed in the
frozen state. This is particularly relevant for free thiols in the absence of
NEM; thus free thiol concentrations reported in this exploratory study
should not be compared to literature values as they do not reflect
physiological concentrations. However, the analytical method used in
the present study [42] was not available at the time of sample collection
and all samples were treated in an identical fashion.
Apart from the altitude setting, redox metabolomics appears to offer
new ways of targeting and personalizing medicine. These results show
that small molecules important to whole-body redox regulation appear
have very distinct response patterns in different individuals exposed to
identical stressors such that each participant revealed his/her unique
metabolic signature. The implications of this finding remain to be ex-
plored in detail, but may potentially be far-reaching–in particular, if it
allowed personalised metabolic phenotyping based on the (epi)genetic
make-up and exposome experience of an individual. In the future, a
more refined and deeper understanding of exactly how these stress
response pathways work together as part of the RSI could offer new
ways of detecting, monitoring and treating different diseases; it may
even be of use in characterizing the pharmacological action of drugs in
vivo.
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